Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Francesca Ricciardiello"'
Autor:
Francesca Ricciardiello, Laura Bergamaschi, Humberto De Vitto, Yang Gang, Taiping Zhang, Roberta Palorini, Ferdinando Chiaradonna
Publikováno v:
Cells, Vol 10, Iss 2, p 431 (2021)
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related death and the search for a resolutive therapy is still a challenge. Since KRAS is commonly mutated in PDAC and is one of the main drivers of PDAC progression, its inhibition
Externí odkaz:
https://doaj.org/article/ee413be52a5044f6a92f5062dc76e08b
Autor:
Yibo Fu, Francesca Ricciardiello, Gang Yang, Jiangdong Qiu, Hua Huang, Jianchun Xiao, Zhe Cao, Fangyu Zhao, Yueze Liu, Wenhao Luo, Guangyu Chen, Lei You, Ferdinando Chiaradonna, Lianfang Zheng, Taiping Zhang
Publikováno v:
Cells, Vol 10, Iss 3, p 497 (2021)
The first-line chemotherapies for patients with unresectable pancreatic cancer (PC) are 5-fluorouracil (5-FU) and gemcitabine therapy. However, due to chemoresistance the prognosis of patients with PC has not been significantly improved. Mitochondria
Externí odkaz:
https://doaj.org/article/dbc17bdf03f24c94a9c9f3213da6345d
Publikováno v:
Genomics Data, Vol 9, Iss C, Pp 100-104 (2016)
Forskolin (FSK) induces activation of protein kinase A (PKA). This activation protects specifically some cancer cells from death induced by glucose starvation. Cell effects upon FSK treatment prompted us to investigate in detail the physiological rol
Externí odkaz:
https://doaj.org/article/b405897ac2474748936de129e8dc7576
Autor:
Roberta Palorini, Giuseppina Votta, Yuri Pirola, Humberto De Vitto, Sara De Palma, Cristina Airoldi, Michele Vasso, Francesca Ricciardiello, Pietro Paolo Lombardi, Claudia Cirulli, Raffaella Rizzi, Francesco Nicotra, Karsten Hiller, Cecilia Gelfi, Lilia Alberghina, Ferdinando Chiaradonna
Publikováno v:
PLoS Genetics, Vol 12, Iss 3, p e1005931 (2016)
Cancer cells often rely on glycolysis to obtain energy and support anabolic growth. Several studies showed that glycolytic cells are susceptible to cell death when subjected to low glucose availability or to lack of glucose. However, some cancer cell
Externí odkaz:
https://doaj.org/article/1dffd9bb091d49a68263f73cbf38e7da
Publikováno v:
Cells, Vol 7, Iss 6, p 53 (2018)
Alterations in glucose and glutamine utilizing pathways and in fatty acid metabolism are currently considered the most significant and prevalent metabolic changes observed in almost all types of tumors. Glucose, glutamine and fatty acids are the subs
Externí odkaz:
https://doaj.org/article/9f6924e6dda74f7cbe264cdfda38bd92
Autor:
Laura Bergamaschi, Ferdinando Chiaradonna, Humberto De Vitto, Francesca Ricciardiello, Yang Gang, Taiping Zhang, Roberta Palorini
Publikováno v:
Cells
Volume 10
Issue 2
Cells, Vol 10, Iss 431, p 431 (2021)
Volume 10
Issue 2
Cells, Vol 10, Iss 431, p 431 (2021)
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related death and the search for a resolutive therapy is still a challenge. Since KRAS is commonly mutated in PDAC and is one of the main drivers of PDAC progression, its inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223093f940b27adb59313fd6be92866e
Autor:
Zhe Cao, Wenhao Luo, Jianchun Xiao, Ferdinando Chiaradonna, Francesca Ricciardiello, Jiangdong Qiu, Taiping Zhang, Gang Yang, Lei You, Guangyu Chen, Lianfang Zheng, Fangyu Zhao, Yueze Liu, Hua Huang, Yibo Fu
Publikováno v:
Cells
Cells, Vol 10, Iss 497, p 497 (2021)
Cells, Vol 10, Iss 497, p 497 (2021)
The first-line chemotherapies for patients with unresectable pancreatic cancer (PC) are 5-fluorouracil (5-FU) and gemcitabine therapy. However, due to chemoresistance the prognosis of patients with PC has not been significantly improved. Mitochondria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f3e1f86c4ea6a26c8ac6aeabe170d1
https://pubmed.ncbi.nlm.nih.gov/33669111
https://pubmed.ncbi.nlm.nih.gov/33669111
Autor:
Jin Gu, Humberto De Vitto, Yupei Zhao, Ferdinando Chiaradonna, Yang Gang, Barbara La Ferla, Francesca Ricciardiello, Fangyu Zhao, Roberta Palorini, Taiping Zhang, Quanxiao Li, Wenfang Guan, Lei You, Marco Giampà
Different evidence has indicated metabolic rewiring as a necessity for pancreatic cancer (PC) growth, invasion, and chemotherapy resistance. A relevant role has been assigned to glucose metabolism. In particular, an enhanced flux through the Hexosami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a13c818c06e51dbdd48a09f9eb273dc
http://hdl.handle.net/10281/268241
http://hdl.handle.net/10281/268241
Autor:
Giancarlo Mauri, Roberta Palorini, Giuseppina Votta, Ferdinando Chiaradonna, Humberto De Vitto, Francesca Ricciardiello, Lilia Alberghina, Simone Spolaor, Paolo Cazzaniga, Daniela Besozzi, Marco S. Nobile
Publikováno v:
Bioinformatics
Bioinformatics, 36(7), 2181-2188. Oxford University Press
Bioinformatics, 36(7), 2181-2188. Oxford University Press
MotivationThe elucidation of dysfunctional cellular processes that can induce the onset of a disease is a challenging issue from both the experimental and computational perspectives. Here we introduce a novel computational method based on the couplin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05d9d60b75636ffee0d1110b127c7343
http://hdl.handle.net/10281/255148
http://hdl.handle.net/10281/255148
Autor:
Roberta Palorini, Giuseppe D'Orazio, Luca De Gioia, Giuseppina Votta, Alice Paiotta, Ferdinando Chiaradonna, Francesca Ricciardiello, Barbara La Ferla, Luca Zoia
Publikováno v:
European Journal of Organic Chemistry. 2018:1946-1952
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffb78fb4fcd70274ac44714a629d3c4a
https://doi.org/10.1002/ejoc.201800183
https://doi.org/10.1002/ejoc.201800183